首页> 外文期刊>Scientific reports. >Acellular Urethra Bioscaffold: Decellularization of Whole Urethras for Tissue Engineering Applications
【24h】

Acellular Urethra Bioscaffold: Decellularization of Whole Urethras for Tissue Engineering Applications

机译:无细胞尿道Bioscodd:组织工程应用的整个尿道的脱细胞化

获取原文
           

摘要

Patients with stress urinary incontinence mainly suffer from malfunction of the urethra closure mechanism. We established the decellularization of porcine urethras to produce acellular urethra bioscaffolds for future tissue engineering applications, using bioscaffolds or bioscaffold-derived soluble products. Cellular removal was evaluated by H&E, DAPI and DNA quantification. The presence of specific ECM proteins was assessed through immunofluorescence staining and colorimetric assay kits. Human skeletal muscle myoblasts, muscle progenitor cells and adipose-derived stromal vascular fractions were used to evaluate the recellularization of the acellular urethra bioscaffolds. The mechanochemical decellularization system removed ~93% of tissue’s DNA, generally preserving ECM’s components and microarchitecture. Recellularization was achieved, though methodological advances are required regarding cell seeding strategies and functional assessment. Through microdissection and partial digestion, different urethra ECM-derived coating substrates were formulated (i.e. containing smooth or skeletal muscle ECM) and used to culture MPCs in vitro. The skeletal muscle ECM substrates enhanced fiber formation leading to the expression of the main skeletal muscle-related proteins and genes, as confirmed by immunofluorescence and RT-qPCR. The described methodology produced a urethra bioscaffold that retained vital ECM proteins and was liable to cell repopulation, a crucial first step towards the generation of urethra bioscaffold-based Tissue Engineering products.
机译:患有压力尿失禁的患者主要患有尿道闭合机制的故障。我们建立了猪尿道的脱细胞,为未来组织工程应用生产了无细胞尿道Biosc形,使用BioscaffOlds或Bioscaffold衍生的可溶性产品。通过H&E,DAPI和DNA定量评估细胞去除。通过免疫荧光染色和比色测定试剂盒评估特异性ECM蛋白的存在。人体骨骼肌肌细胞,肌祖细胞和脂肪衍生的基质血管级分,用于评估细胞尿道Bioscaffolds的透速。机械化学脱细胞化系统除去〜93%的组织DNA,通常保持ECM的组分和微体系结构。虽然有关细胞播种策略和功能评估,但仍然实现了透彻的方法。通过微粉和部分消化,配制不同的尿道ECM衍生的涂层基材(即含有光滑或骨骼肌ECM)并用于体外培养MPCs。骨骼肌ECM基质增强纤维形成,导致主要骨骼肌相关蛋白和基因的表达,通过免疫荧光和RT-QPCR证实。所描述的方法产生了一种尿道生物关节,保留了重要的ECM蛋白并易于细胞重新掺杂,这是促进基于尿道Bioscudold的组织工程产品的关键第一步。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号